B Amyloid 1 - 42 / P-Tau 217 Ratio

Individuals experiencing memory loss, confusion, or other cognitive changes. People with a family history of Alzheimer’s disease or dementia who want early risk assessment. Patients advised by a neurologist or physician for evaluation of neurodegenerative conditions.